Count Down to relaunch

GSK – Egypt will establish new company

GSK – Egypt will establish new company

ArabFinance:  GlaxoSmithKline, the UK-based company and the owner of GSK- Egypt, will establish a new company to market the consumer health products, while GlaxoSmithKline will manufacture and market pharmaceutical/vaccines, according to the GSK Egypt’s statement filed to the Egyptian Exchange.

GSK – Egypt restructures by separating the pharmaceutical/vaccines and consumer healthcare business globally as a general strategy in all markets and set up two independent UK-based global companies for that purpose.

The listed company distributed annual cash dividends of EGP 0.50 per share on July 7th.

GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.

#Related keywords


Recommended Stocks

04 Oct 2021
United Housing & Development UNIT

All rights reserved to Arab Finance 2020 ©

Back to top